Floatz logo

SFX-01 (SULFORAPHANE STABILIZED WITH .ALPHA. CYCLODEXTRIN)

Dermatitis

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Dermatitis cohort.

Asset / SponsorPhaseRating
Epigallocatechin-3-Gallate
Shandong Cancer Hospital and Institute
Phase 2CCC
AE-BROCCOLI
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
D

Same molecule, other indications

SFX-01 (SULFORAPHANE STABILIZED WITH .ALPHA. CYCLODEXTRIN) is also rated in:

HIV infectious diseaseDormant
B
Indicative ·
62 / 100
View asset →
breast neoplasmDormant
B
Indicative ·
57 / 100
View asset →
prostate cancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →